Carmen Spaccarotella, MD

Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study

Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study

05/01/2021

Martino Pepe , MD, PhD;

Alberto Morello , MD;

Antonio L. Bartorelli , MD;

Carmen Spaccarotella , MD;

Michele Cimmino , MD;

Anna Sonia Petronio , MD;

Luca Testa , MD, PhD;

Maurizio Tespili , MD;

Alessandro Iadanza , MD;

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Giacomo Frati , MD, MSc;

Giuseppe G.L. Biondi-Zoccai , MD, PhD;

Sergio Berti , MD;

Enrico Romagnoli , MD, PhD;

Damiano Regazzoli , MD;

To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R,...

To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R,...

To learn more about the...

05/01/2021

Journal of Invasive Cardiology

Pepe RISPEVA TN

Original Contribution

Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry

05/06/2022

Marcello De Giosa ;

Gennaro Sardella , MD, PhD;

Giuseppe G.L. Biondi-Zoccai , MD, PhD;

Antonio L. Bartorelli , MD;

Francesco Bedogni , MD, PhD;

Sergio Berti , MD;

Martino Pepe , MD, PhD;

Palma Luisa Nestola , MD;

Alberto Morello , MD;

Alessandro Iadanza , MD;

Carmen Spaccarotella , MD;

Arturo Giordano , MD, PhD;

Michele Cimmino , MD;

Nicola Corcione , MD;

Michele Albanese , MD;

Paolo Ferraro , MD;

The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...

The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...

The differential outcomes...

05/06/2022

Journal of Invasive Cardiology

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar